Healthy People
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
CT
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 program1
Test preparation：Methylcholine chloroacetate for inhalationPhase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chia Tai TianQing Pharmaceutical GroupTest preparation：Methylcholine chloroacetate for inhalation
Qilu PharmaceuticalQL1206
Qilu PharmaceuticalQL1206
Clinical Trials (3)
NCT06730620Chia Tai TianQing Pharmaceutical GroupTest preparation：Methylcholine chloroacetate for inhalation
Bioequivalence Study of Methacholine Chloride
Start: Jan 2024Est. completion: Feb 2024
Phase 4Completed
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
Start: Oct 2019Est. completion: Oct 2020
Phase 1Unknown
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
Start: Aug 2018Est. completion: May 2019
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space